Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I'm annoyed as the next person how Vlad can leave his investors in the dark. Nothing RNSable since the raise... hmmm
Trust him and be patient is Vlad's mantra. It's certainly not changed! and I do, completely. But there is no doubt patience is being tested. We will get there, 100% not if, but when... but this lull is dull.
Not sure what you are looking for from me? Its complex.
Its a paper documenting the potential advancements in their CAR T treatment? From 16 months ago. Exploring adding a second types of treatment along with CAR T down the line.
I notice the paper was produced with HEMO and Novartis, both PENN partners. Hope Novartis like Vlad's work ;-)
Pretty sure there'd be one pumpky if they were not accepted. You know Vlad doesnt like undoing the purse strings for an RNS for micro stages. Indications are, as things stand, knowing the earlier runs were fine, that all is well. Unless you like a witter?
One2one, so you're saying HEMO will have something to offer once it enters clinical trials... good stuff. Shouldn't be long now.
Pumpky
Can I ask exactly are you waiting for with Nano?
I mean, its quite clear what HEMOs shorter term targets are. What are Nanos? That settlement looks to have made what I thought was a big chunk of their IP portfolio disappear. What they got coming up?
With no RNSs on the subject you either:-
a). Assume everything is going swimmingly with the whole process (until the point the RNS is require for submission/acceptance)
b) Assume it isn't (Negative stance with little basis as imo If something was wrong or there were any problems, there would be an RNS confirming so)
Its as simple as that for me.
Speculating and buying pre news Godzilla?! Interesting concept... it might catch on :-) lol
And round in circles everyone goes with Stu and pumper.
They will say positive posters are ramping with no facts but the moaners simply are negative with no facts. Mocking anyone positive with no basis of casting a negative shadow on HEMO whatsoever. There is no reasoned response that will win an argument with them. They will always have the last word! So better off not responding IMO!
The big news will drop when it's ready and it wont be much longer now as the IND submission is checked, checked and checked again. The FDA are very intense with the questioning so it makes sense they are being uber thorough with the answers to all the questions and the enclosures they are providing to minimise the push back, pre empting any qs.
Sit back and relax. HEMO is doing things as a proper company should, thoroughly.
That would make sense
But pretty sure the results of the first patient treatment we will get to know what is going on. Either it does not work and the patient does not recover. Or it does... as well hope and then what...?!
I personally dont think we will be waiting very long into the trails to be in receipt of initial findings.
So how many patients will HEMO need to take on the trial?
An IND oncology drug, I'd imagine we are talking just a handful. Results will begin to be gathered pretty quickly in reality.also.
if I were ill with refractory or relapsed AML I'd be keen as mustard to get involved. I hope we can help some people very soon.
HemoKnowledge,
Most people understand that FDA submissions are complex and there any many requirements. It makes complete sense to ensure it is right before it is issued.
The fact remains until it is submitted many investors will continue to have their doubts about HEMO and pained long term holders like me have to read some of the drivel that is posted on this site questioning HEMOs credibility.
I guess it's time to switch off and relax. I trust Vlad has everything in hand. I look forward to reading the RNS confirming submission sooner rather than later!
You cant really value it yet, mind boggling potential.
Having reached the point where Vlad is happy to talk properly about it now and give more details tells us he's happy the IP is now sufficiently protected and the testing is advanced enough for him to know it works well so far. No major hiccups.
CBR is going to be epic for the world! And HEMO!
If it provides an off the shelf cure to most viruses out there. Including new and yet undiscovered viruses?
in vivo tests on specific viruses taking place already.
Big pharma will be queuing up. No two ways about it.
Something a lot more fun to think about...
1.1 billion shares aint no thing if the company is worth £5b!